Abstract
Chemotherapy with anticancer drugs is known to be beneficial, but like a double-edged sword, it has its own demerits in the form of adverse effects. Cancer chemotherapy-induced thrombocytopenia is troublesome, and platinum-based regimens, namely carboplatin and cisplatin, are known to cause it very commonly. Gemcitabine, in combination with platinum compounds, is known to cause severe thrombocytopenia. Hence, we report a case of thrombocytopenia induced by gemcitabine when used as a single agent in the treatment of ovarian cancer.
Original language | English |
---|---|
Pages (from-to) | 17-18 |
Number of pages | 2 |
Journal | Asian Journal of Pharmaceutical and Clinical Research |
Volume | 10 |
Issue number | 5 |
DOIs | |
Publication status | Published - 01-01-2017 |
Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Pharmacology
- Pharmaceutical Science
- Pharmacology (medical)